United Therapeutics (UTHR) Tops Q1 EPS by $1.69
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $541.83 -0.57%
EPS Growth %: +11.9%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: +11.9%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.03, $1.69 better than the analyst estimate of $3.34. Revenue for the quarter came in at $461.9 million versus the consensus estimate of $420.02 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Horizon Bancorp faces $3M jury verdict in auto repossession case
- Alcoa agrees to buy South32 assets for $4.1 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
